BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24270123)

  • 21. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ; Kim YK; Lee MW; Lee WJ; Kim YS; Kim SH; Choi D; Rhim H
    Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T.
    Del Grande F; Subhawong T; Weber K; Aro M; Mugera C; Fayad LM
    Radiology; 2014 May; 271(2):499-511. PubMed ID: 24495264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.
    Hansford BG; Karademir I; Peng Y; Jiang Y; Karczmar G; Thomas S; Yousuf A; Antic T; Eggener S; Oto A
    Acad Radiol; 2014 May; 21(5):569-77. PubMed ID: 24703469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
    Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
    Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.
    Park MS; Kim S; Patel J; Hajdu CH; Do RK; Mannelli L; Babb JS; Taouli B
    Hepatology; 2012 Jul; 56(1):140-8. PubMed ID: 22370974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
    Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
    Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial cancer: preoperative staging using three-dimensional T2-weighted turbo spin-echo and diffusion-weighted MR imaging at 3.0 T: a prospective comparative study.
    Hori M; Kim T; Onishi H; Imaoka I; Kagawa Y; Murakami T; Nakamoto A; Ueguchi T; Tatsumi M; Enomoto T; Kimura T; Tomiyama N
    Eur Radiol; 2013 Aug; 23(8):2296-305. PubMed ID: 23508278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative T staging of gastric cancer: comparison of diffusion- and T2-weighted magnetic resonance imaging.
    Liu S; He J; Guan W; Li Q; Zhang X; Mao H; Yu H; Zhou Z
    J Comput Assist Tomogr; 2014; 38(4):544-50. PubMed ID: 24733002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of diffusion-weighted and dynamic contrast-enhanced MR in predicting parametrial invasion in cervical stromal ring focally disrupted stage IB-IIA cervical cancers.
    Song J; Hu Q; Ma Z; Zhang J; Chen T
    Abdom Radiol (NY); 2019 Sep; 44(9):3166-3174. PubMed ID: 31377834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability.
    Hricak H; Gatsonis C; Coakley FV; Snyder B; Reinhold C; Schwartz LH; Woodward PJ; Pannu HK; Amendola M; Mitchell DG
    Radiology; 2007 Nov; 245(2):491-8. PubMed ID: 17940305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine cervical carcinoma: preoperative staging with 3.0-T MR imaging--comparison with 1.5-T MR imaging.
    Hori M; Kim T; Murakami T; Imaoka I; Onishi H; Tomoda K; Tsutsui T; Enomoto T; Kimura T; Nakamura H
    Radiology; 2009 Apr; 251(1):96-104. PubMed ID: 19221059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
    Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the accuracy of diffusion-weighted imaging versus dynamic contrast enhancement magnetic resonance imaging in characterizing focal liver lesions.
    Tappouni R; ElKady RM; Sarwani N; Dykes T
    J Comput Assist Tomogr; 2013; 37(6):995-1001. PubMed ID: 24270124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating Myometrial Invasion in Endometrial Cancer: Comparison of Reduced Field-of-view Diffusion-weighted Imaging and Dynamic Contrast-enhanced MR Imaging.
    Takeuchi M; Matsuzaki K; Harada M
    Magn Reson Med Sci; 2018 Jan; 17(1):28-34. PubMed ID: 28515411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
    Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
    Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.